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Abstract
Experimental bone marrow transplantation (BMT) in mice is commonly used to assess the
role of immune cell-specific genes in various pathophysiological settings. The application of
BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-
induced obesity. We set out to characterize metabolic tissues that may be affected by the
BMT procedure and impair the HFD-induced response. Male C57BL/6 mice underwent syn-
geneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-
fat diet (LFD) or HFD for 16 weeks. HFD-induced obesity was reduced in mice after BMT as
compared to HFD-fed control mice, characterized by both a reduced fat (-33%; p<0.01) and
lean (-11%; p<0.01) mass, while food intake and energy expenditure were unaffected. As
compared to control mice, BMT-treated mice had a reduced mature adipocyte volume
(approx. -45%; p<0.05) and reduced numbers of preadipocytes (-38%; p<0.05) and macro-
phages (-62%; p<0.05) in subcutaneous, gonadal and visceral white adipose tissue. In
BMT-treated mice, pancreas weight (-46%; p<0.01) was disproportionally decreased. This
was associated with reduced plasma insulin (-68%; p<0.05) and C-peptide (-37%; p<0.01)
levels and a delayed glucose clearance in BMT-treated mice on HFD as compared to control
mice. In conclusion, the reduction in HFD-induced obesity after BMT in mice is at least partly
due to alterations in the adipose tissue cell pool composition as well as to a decreased pan-
creatic secretion of the anabolic hormone insulin. These effects should be considered when
interpreting results of experimental BMT in metabolic studies.
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Introduction
Overweight and obesity are presently affecting close to 50% of the adult population in many
Western countries and are leading to an epidemic of associated metabolic comorbidities such
as type 2 diabetes and cardiovascular diseases [1]. Obesity is associated with adipose tissue
inflammation, characterized by abnormal production of pro-inflammatory cytokines and che-
mokines by adipocytes and infiltrating immune cells, which ultimately leads to chronic sys-
temic inflammation [2]. Most of the immune cells are derived from bone marrow [3]. A
widely used tool to study the role of immune cells in many immune-associated disorders is
experimental bone marrow transplantation (BMT) in mouse models. With this technique,
host hematopoietic cells are depleted by lethal total body irradiation (TBI) and replaced by
donor bone marrow cells harbouring genetic alterations in a relevant inflammatory pathway
[4].
Experimental BMT in mice is relatively easy, effective and cost-efficient. However, a draw-
back is that BMT, and in particular the lethal TBI that is part of the procedure, may induce
metabolic disturbances per se. Poglio et al. [5] showed that mice have a lower body weight
seven days post BMT and that irradiation dose dependently and acutely reduced white adipose
tissue (WAT) fat pad weight by decreasing both adipocyte volume and number. Another study
showed that BMT reduced adiposity in genetically obese ob/ob mice. These mice stopped gain-
ing weight two months after TBI, while the control mice gained weight continuously [6].
We set out to investigate the mechanism underlying the metabolic phenotype of mice fed a
low-fat normal diet (hereafter called LFD) or high-fat diet (HFD) after BMT, and focused on
body composition as well as glucose and insulin metabolism. We show that BMT treatment
indeed significantly decreased diet-induced obesity which involves altered characteristics of
white adipocytes and a decreased insulin secretion in response to a HFD.
Material & methods
Animals
Male C57BL/6 mice were purchased from Charles River (Maastricht, The Netherlands) and
housed under standard conditions with free access to water and food. After a period of two
weeks acclimatisation, half of the mice underwent syngeneic BMT. In short, mice received 8
Gy X-ray radiation using an Orthovolt and the day thereafter an intravenous injection in the
tail with donor bone marrow cells. The donor mice were male C57BL/6 mice from similar age.
All mice, both BMT-treated and non BMT-treated control mice, received antibiotics-water
(Amfotericine B, Ciprofloxaci, Polymixin B) from 3 days before until 4 weeks after BMT. After
8 weeks recovery on chow diet, mice were fed low-fat normal diet (LFD; 10% energy from lard
D12450B) or a HFD (60% energy derived from lard fat D12492, Research Diet Services, Wijk
bij Duurstede, The Netherlands) for 16 weeks to induce obesity (n = 7–12 per group). The
experiment started with n = 12 per group. During the study one mouse died from the BMT-
treated HFD-group within the recovery period and 4 mice were euthanized during the HFD-
feeding due to deteriorated general health condition. This resulted at the end in n = 7 mice for
the BMT-treated HFD-group and n = 12 mice for the other 3 groups. Body weight was mea-
sured weekly during the entire experiment. Lean and fat mass were monitored by MRI-based
body composition analysis (Echo MRI, Echo Medical Systems, USA). Twenty-four weeks
after BMT, mice were anesthetized by a subcutaneous injection of a mixture of Neurotranq,
Midazolam and fentanyl. Mice were bled via the eye and the following organs were dissected:
heart, liver, pancreas, thymus, spleen, skeletal muscle quadriceps, and white adipose tissue
pads from the gonadal (gWAT, unilateral), subcutaneous (sWAT, unilateral) and visceral
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(vWAT) region. All experiments were approved by the animal ethics committee of the Leiden
University Medical Center (protocol no. 121031).
Intravenous glucose tolerance test
At 12 weeks LFD or HFD feeding, an intravenous glucose tolerance test (IVGTT) was performed.
Prior to the IVGTT, mice were fasted for 6 hours. Blood samples were collected from the tail vein
immediately before (t = 0 min) and 2, 5, 15, 30, 90 and 120 minutes after intravenous injection
with glucose (2 mg/g body weight). Plasma glucose concentrations were quantified using the Glu-
cose Start Reagent Method according to manufacturer’s instructions (Instruchemie, Delftzijl, The
Netherlands). Plasma insulin and C-peptide levels were measured at 12 weeks LFD or HFD using
the Ultra Sensitive Mouse Insulin ELISA Kit and Mouse C-Peptide ELISA Kit, respectively,
according to manufacturer’s instructions (Crystal Chem, Downers Grove, USA).
Adipose tissue characterization
Adipose tissue from the gWAT (unilateral), sWAT (unilateral) and vWAT region were
removed from the mice after 16 weeks of LFD or HFD and kept in PBS. The tissues were
minced, digested with 0.5 g/l collagenase (Type 1) in DMEM/F12 with 20 g/l of dialyzed
bovine serum albumin for 1 h at 37˚C (BSA, fraction V; Sigma, ST Louis, USA), and filtered
through a nylon mesh (236 μm pore). Adipocytes were obtained from the surface of the filtrate,
and washed two times with PBS. Cell size and volume of mature adipocytes were determined
from micrographs (approx. 1,000 cells per WAT sample) using image analysis software that
was developed in house in MATLAB (MathWorks, Natick, MA). The adipocyte number per
fat pad was calculated from the fat pad mass and adipocyte size.
Stromal vascular cells were isolated from the adipose tissue filtrate and fixed in 0.5% parafor-
maldehyde as described [7]. The number of stromal vascular cells per fat pad was determined
using an automated cell counter (TC10, Biorad, CA, USA). The percentage of preadipocytes
within the stromal vascular fraction was measured using flow cytometry. The stromal vascular
cells were stained with fluorescently labeled antibodies for CD45, CD31, CD34 and F4/80 (Bio-
Legend, CA, USA). Cells were measured on an LSR II flow cytometer (BD Biosciences, Breda,
the Netherlands). Data was analyzed using FlowJo software (FlowJo, Oregon, USA). Preadipo-
cytes were determined by selecting the CD45-CD31-CD34+ cells. Macrophages were deter-
mined by selecting the CD45+F4/80+ cells.
Histological examination of the pancreas
The pancreas was isolated, weighed and fixed in a random orientation in 4% paraformalde-
hyde and embedded in paraffin. Beta cell area and mass of n = 5 mice per group were quanti-
fied as described before [8]. For the identification of beta cells, sections were immunostained
with rabbit anti-insulin IgG (1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
for 1 hour followed by HRP- or AP-conjugated secondary antibodies (1:100 dilution) for 1
hour. Sections were developed with 3,3’-diaminobenzidine tetrahydrochloride (DAB) and
counterstained with hematoxylin. For determining the beta cell mass, 3–4 insulin-DAB stained
sections (200 mm apart) were digitally imaged (Panoramic MIDI, 3DHISTECH, Hungary).
The area of the beta cells within the pancreas were determined using an in house developed
image analysis program (Stacks 2.1, LUMC, Leiden, The Netherlands), excluding large blood
vessels, larger ducts, adipose tissue and lymph nodes. The area of clusters containing beta cells
was individually measured and used to determine the average beta cell cluster area. Beta cell
mass was determined by the percentage of beta cell area to pancreas area multiplied by the
total pancreas weight, as described previously [8].
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Faecal triglycerides and free fatty acids measurement
Faecal samples were weighted and manually pulverized. Faecal powder was dissolved in a mix-
ture of MilliQ water, methanol and hexane. Samples were vortexed, centrifuged at 14,000 g for
1 minute and the hexane supernatant was transferred into a clean tube. Additional hexane was
added. After again vortexing and centrifuging at 14,000 g for 1 minute, the hexane fractions
were transferred into new clean tubes. The hexane was evaporated using N2. Triton-chloro-
form was added to the pellets and the samples were incubated 10 minutes at 37˚C. Triglycer-
ides were measured using the enzymatic kit 11488872 (Roche Molecular Biochemicals,
Indianapolis, IN, USA). Free fatty acids were measured using Wako NEFA-C kit from Wako
Diagnostics (Instruchemie, Delfzijl, The Netherlands).”
Statistics
Data are presented as means ± SD. BMT-treated mice were compared to control mice using
unpaired student T-test analysis. Correlation analysis was performed using linear regression
analysis. The regression lines of the BMT-treated mice versus control mice were compared to
see whether the correlations differed between BMT-treated and control mice. First it was
tested whether slopes of the lines differed and then whether intercepts of the lines differed.
When the slopes and intercepts were not significantly different, linear regression analyses
was performed on pooled data of both groups,. All statistical analyses were performed using
GraphPad Prism version 6 (GraphPad software, San Diego, CA, USA).
Results
After LFD or HFD, body weight gain, but not energy expenditure and
food intake, is decreased in BMT-treated mice
We first determined the effects of LFD or HFD on body weight gain and body composition
as well as on food intake and energy expenditure in mice that had undergone a syngeneic
BMT versus controls. The BMT procedure caused a reduction in body weight already within
a few days after BMT while mice were fed chow diet (Fig 1A and 1B). After the diet switch to
LFD or HFD at t = 0 weeks, the body weight gain diverged between BMT-treated and control
mice (Fig 1A and 1B). This was most apparent for HFD-fed BMT mice. Analysis of body
composition by Echo-MRI showed decreased lean mass (Fig 1C) and fat mass (Fig 1D) both
on LFD and HFD in BMT-treated mice as compared to controls. However, the decreased
body weight gain was mainly due to decreased fat mass expansion, especially in the HFD-fed
BMT-treated mice. Individual indirect calorimetry measurements using metabolic cages
revealed that the decrease in body weight gain could neither be explained by decreased food
intake nor by increased energy expenditure in LFD- or HFD-fed BMT-treated mice. There
was no difference in fat oxidation or carbohydrate oxidation between BMT-treated and con-
trol mice (S1 Fig).
LFD- and HFD-induced increases in white adipose tissue weight,
adipocyte size and macrophage infiltration are diminished by BMT
treatment
To investigate whether BMT affects adipose tissue after LFD or HFD, sWAT, vWAT and
gWAT of BMT-treated and control mice were characterised. On LFD, the weights of all indi-
vidual fat pads were reduced at the end of the study in BMT-treated mice as compared to con-
trol mice (Fig 2A). On HFD, the weight of sWAT and vWAT, but not gWAT, was reduced in
the BMT-treated group as compared to control mice (Fig 2A). The adipocyte volumes in the
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Fig 1. BMT decreased diet-induced obesity. (A) Male C57BL/6 mice underwent BMT at time point 0 weeks. From 0
weeks until week 8, mice were fed a chow diet and from time point 8 weeks, mice were fed either a 10% LFD. (B) Body
weight gain of BMT-treated mice, over a period of 16 weeks LFD, was reduced compared to control mice. Values are
means ± SD; n = 7–12; * p<0.05,** p<0.01, *** p<0.001.
https://doi.org/10.1371/journal.pone.0175524.g001
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various fat pads decreased in parallel with decreased fat pad weights (Fig 2B). The number of
mature adipocytes per fat pad was not affected by BMT in the WAT pads neither on LFD nor
on HFD (Fig 2C). However, FACS analyses revealed that in BMT-treated mice the absolute
number of preadipocytes present in adipose tissue was lower in all fat pads on HFD and in the
gWAT and vWAT on LFD, than in the controls (Fig 2D). In addition, the absolute numbers of
macrophages per fat pad in almost all fat pads in mice on LFD and HFD was lower in BMT-
treated mice than in controls (Fig 2E). A clear correlation was observed between gWAT fat
pad weight and macrophage number per fat pad (Fig 2F). Interestingly, at similar fat pad
weight, the number of macrophages was lower in BMT-treated mice than in control mice, as
demonstrated by the downward shifted correlation line (comparison regression lines: slopes
Fslopes = 2.91, p = NS, Fintercepts = 18.49; p<0.01). Collectively, these findings show that LFD-
and HFD-induced WAT expansion is significantly impaired after BMT treatment.
Fig 2. BMT has long term effects on white adipose tissue. (A) Weight of sWAT and vWAT pads was
decreased in BMT-treated mice as compared to control mice. (B) The volume of mature adipocytes was lower
in BMT-treated mice than control mice. (C) The number of mature adipocytes was not affected in the three
WAT pads, (D) but the number of preadipocytes in all three WAT pads was lower in BMT-treated mice than
control mice. (E) Macrophage number per fad pad was lower in the three fat pads of BMT-treated mice vs.
control mice. (F) Linear regression analysis of macrophage number per fat pad and gWAT pad weight showed
decreased macrophage numbers in gWAT in BMT-treated mice compared to control mice. Values are
means ± SD; n = 7–12; * p<0.05, ** p<0.01, *** p<0.001.
https://doi.org/10.1371/journal.pone.0175524.g002
Fig 3. BMT decreased weight of different organs. (A) BMT decreased the weight of liver, thymus, spleen
and the pancreas both on LFD and HFD. (B) Linear regression analysis of pancreas weight and body weight
showed a lower pancreas weight in the BMT-treated mice, independently of body weight. Values are
means ± SD; n = 7–12; * p<0.05, ** p<0.01, *** p<0.001.
https://doi.org/10.1371/journal.pone.0175524.g003
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The weight of non-adipose tissue organs in LFD- and HFD-fed mice is
decreased after BMT treatment
Further characterisation of organs revealed that in LFD- and HFD-fed mice, weight of liver,
thymus and spleen was lower in BMT-treated mice than in controls (Fig 3A). Heart weight
was lower in LFD-fed but not in HFD-fed BMT-treated mice. BMT treatment did not affect
skeletal muscle quadriceps weight. Remarkably, both in LFD- and HFD-fed mice, pancreas
weight was reduced by approx. 45% in BMT-treated mice (p<0.01) (Fig 3A). Liver, thymus,
spleen and pancreas weight correlated with body weight (data not shown). However, BMT-
treated mice had lower pancreas weights than control mice at similar body weights, as demon-
strated by the significantly downward shifted correlation line (comparison regression lines:
Fslopes = 0.109, p = NS, Fintercepts = 56.81; p<0.01; Fig 3B). This difference in organ weight rela-
tive to body weight between the mouse groups was not seen for liver, thymus and spleen. The
pancreas was further characterized by histological examination. Surprisingly, total beta cell
area or beta cell mass per total pancreas was not affected by BMT treatment (Fig 4).
Insulin production and glucose tolerance are lower in HFD-fed mice after
BMT treatment
As pancreas weight relative to body weight was disproportionally reduced in both LFD- and
HFD-fed mice after BMT treatment, we further assessed the effect of BMT treatment on glu-
cose and insulin metabolism. Neither on LFD nor on HFD fasting plasma glucose concentra-
tions were affected by BMT treatment (Fig 5A). To investigate whether BMT itself also affected
fasting plasma glucose levels independently of body weight, linear regression analysis was per-
formed on fasting plasma glucose levels versus body weight for BMT-treated and control mice
Fig 4. BMT did not affect pancreatic beta cell area and beta cell mass. (A) Beta cell area and (B) beta cell
mass were not different in the BMT-treated mice. Values are means ± SD; n = 5.
https://doi.org/10.1371/journal.pone.0175524.g004
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separately. BMT-treated mice tended to have a higher fasting plasma glucose concentration
with similar body weights (Fig 5B: comparison regression lines: Fslopes = 0.065, p = NS, Finter-
cepts = 3.72; p = 0.06). Interestingly, fasting plasma insulin concentration was only lower in
BMT-treated mice than in controls when they were fed a HFD (-68%; p<0.05; Fig 5C). These
decreased insulin concentrations in the metabolically-challenged BMT-treated mice may be
the result of a lower insulin production and, therefore, fasting plasma C-peptide levels were
measured. Indeed, BMT reduced fasting plasma C-peptide levels compared to controls only in
HFD-fed mice (-37%; p<0.01; Fig 5D). The pancreas weight positively correlated with C-pep-
tide levels (R2 = 0.244; p<0.01; Fig 5E), indicating that the reduced pancreas volume in BMT
mice was linked to lower insulin secretion. In line with reduced insulin secretion, HFD-fed
BMT-treated mice were more glucose intolerant during an IVGTT than control mice, as
reflected by an increased glucose clearance half-life (Fig 5F).
Discussion
The current study shows that BMT induces long-term metabolic abnormalities in mice, with
decreased body weight gain upon LFD and, especially, upon HFD feeding. This reduced body
weight gain was mainly due to reduced fat mass gain, and to a lesser extent due to reduced lean
mass gain. BMT-treated mice displayed decreased adipocyte hypertrophy both on LFD and
HFD, whereas adipocyte hyperplasia was not affected 24 weeks after BMT. In addition to
reduced adipose tissue, BMT led to a decreased size of other (metabolic) organs such as liver,
thymus, spleen and pancreas, which, except for the pancreas, was in line with the reduction in
body weight. The pancreas weight disproportionally decreased after BMT and likely explains
the decreased plasma insulin levels and insulin secretion on a HFD after BMT.
We observed smaller adipocytes in BMT-treated mice, which could not be explained by a
reduced food intake or increased energy expenditure as determined by indirect calorimetry.
The smaller adipocytes might be explained by alterations in preadipocyte function. Mature
adipocytes are terminally differentiated cells which originate from preadipocytes present in
adipose tissue [9–11]. Recently, Nylander et al. [12] showed that a single sub-lethal irradiation
dose of 6 Gy attenuated the adipogenic potential of preadipocytes via alterations in intracellu-
lar and epigenetic pathways. A reduced preadipocyte differentiation capacity may explain the
reduced mature adipocyte volumes in our BMT-treated mice.
Our study revealed that also the number of preadipocytes per fat pad was reduced in the
BMT-treated mice, suggesting that the preadipocyte pool used for recruitment of mature adi-
pocytes was decreased by BMT. As both LFD and HFD stimulate energy storage and therefore
likely induce preadipocyte recruitment, a decreased preadipocyte pool may also have contrib-
uted to the decreased adipose tissue growth seen in BMT-treated mice. The mechanism under-
lying the lower preadipocyte numbers in BMT-treated mice remains to be determined. It is
possible that the TBI procedure has depleted preadipocytes or the mesenchymal stem cells in
adipose tissue that are believed to be the precursor cells of the preadipocytes.
Notably, several studies have suggested that progenitor cells derived from bone marrow can
contribute to the development of new adipocytes both in mice [13,14] and humans [15]. This
Fig 5. BMT mice had lower plasma insulin levels and glucose tolerance on a HFD. (A) Fasting plasma
glucose of BMT-treated and control mice did not differ on LFD or HFD. (B) BMT-treated mice tended to
have higher fasting plasma glucose concentrations for similar body weights. (C) BMT-treated mice had
lowered fasting plasma insulin levels only on HFD. (D) BMT-treated mice had lowered plasma C-peptide
concentrations on HFD. (E) There is a linear relation between pancreas weight and fasting plasma C-peptide
concentrations. (F) IVGTT revealed that BMT-treated mice have a higher plasma glucose clearance half-life,
only on HFD. Values are means ± SD; n = 7–12; * p<0.05, ** p<0.01.
https://doi.org/10.1371/journal.pone.0175524.g005
Bone marrow transplantation induces metabolic abnormalities
PLOS ONE | https://doi.org/10.1371/journal.pone.0175524 April 26, 2017 10 / 13
population of bone marrow cells may have been affected by the BMT procedure and thus also
contribute to the reduced adipogenesis. Infiltration of bone marrow-derived macrophages
into WAT tissue is strongly associated with fat pad expansion [16]. Interestingly, the macro-
phage content in WAT fat pads after BMT was disproportionally reduced. Thus, BMT not
only affects the response of adipocyte precursor cells to LFD and HFD, but also the immune
cell composition in the adipose tissue. Since immune cells play a major role in adipose tissue
biology [16,17], our data imply that BMT may also affect WAT function via modulation of the
immune status in this tissue.
The weight of organs is in general strongly associated with body weight. In accordance, obe-
sity induces changes in body composition and increases in organ weights [16]. BMT more
severely reduced pancreas weight than expected based on the reduction in body weight both in
mice on LFD as well as HFD. This was accompanied by a decreased insulin secretion and
decreased plasma insulin levels in BMT mice as compared to control mice on HFD. The fact
that we only observed this difference in insulin levels on a HFD is explained by a HFD-induced
increase in plasma insulin in control mice which was not seen control mice on LFD. BMT-
treated mice were slightly more glucose intolerant than control mice on a HFD, despite a
lower body weight. Pancreatic beta cell mass, however, was not affected by BMT treatment.
Our data together suggest that BMT disproportionally affects the weight of the pancreas,
resulting in reduced insulin responses to a HFD, and modest negative effects on glucose
metabolism.
It was previously suggested that BMT leads to β-cell regeneration after acute streptozotocin
(STZ)-induced injury in mice by triggering recruitment of immature bone marrow-derived
cells to the injured pancreas. This recruitment, subsequently, stimulates stem/progenitor cells
located in the recipient pancreas, resulting in islet regeneration. It was therefore suggested that
BMT can be used as a novel approach to treat T2D [18]. Our results point to the opposite
direction and suggest that BMT may lead to metabolic abnormalities, including reduced insu-
lin secretion and glucose intolerance, which is specifically manifest on HFD. Interestingly,
reduced pancreas volume was also observed in survivors of childhood acute lymphoblastic leu-
kaemia who were treated with BMT [19]. In line with our study, several clinical studies sug-
gests that BMT survivors have an increased risk of developing insulin resistance and T2D
development [16,10,20].
In addition to producing the anabolic hormone insulin, the pancreas plays a major role in
energy metabolism by secreting digestive enzymes such as pancreatic lipases into the gut
where they serve to digest dietary lipids. As BMT reduced the pancreas volume, it is possible
that the exocrine function of the pancreas was affected. Reduced absorption of lipids may thus
in part explain the reduced body fat gain in BMT-treated mice. To elucidate whether there
were differences in pancreatic lipid digestion, we measured faecal triglyceride and free fatty
acids content. For faecal triglycerides we did not find differences between the BMT-treated
and control mice, whereas for faecal free fatty acids there was a slight decrease in BMT-treated
mice on HFD (S2 Fig). These results indicate that pancreatic lipase production was not affected
significantly by BMT. Whether BMT affects the function of other digestive pancreatic enzymes
(such as pancreatic proteases) remains to be elucidated.
Taken together, we conclude that the BMT procedure has multilevel effects on the organism
and affects metabolically important organs. These multi-level effects are associated with meta-
bolic abnormalities that involve both WAT and pancreas dysfunction in response to a HFD.
While BMT is a relatively easy and effective strategy for assessing the role of specific immune-
related genes in pathophysiological studies in mice, the metabolic effects of BMT cannot sim-
ply be neglected and should be seriously considered in study design, goal and interpretation of
the data. Our study may also have clinical implications, as BMT is conducted in humans to
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treat diseases such as leukaemia. Weight loss and insulin resistance should be closely moni-
tored as potential side effects of this therapy.
Supporting information
S1 Fig. BMT did not affect food intake, energy expenditure, fat and carbohydrate oxida-
tion. Indirect calorimetry data using metabolic cages (Phenomaster, TSE Systems, Bad Hom-
burg, Germany) showed (A) Food, (B) energy expenditure, (C) fat oxidation and (D)
carbohydrate oxidation of BMT-treated mice did not differed compared to control mice.
(TIF)
S2 Fig. BMT did not affect faecal triglycerides content. (A) Faecal triglycerides concentra-
tion did not differed between BMT-treated and control mice. (B) There was slightly less free
fatty acids in feces of HFD fed BMT-treated mice compared to the control group.
(TIF)
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